GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » EV-to-EBIT

MicroPort CardioFlow Medtech (HKSE:02160) EV-to-EBIT : -3.34 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MicroPort CardioFlow Medtech's Enterprise Value is HK$1,677.9 Mil. MicroPort CardioFlow Medtech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-502.8 Mil. Therefore, MicroPort CardioFlow Medtech's EV-to-EBIT for today is -3.34.

The historical rank and industry rank for MicroPort CardioFlow Medtech's EV-to-EBIT or its related term are showing as below:

HKSE:02160' s EV-to-EBIT Range Over the Past 10 Years
Min: -154.66   Med: -16.64   Max: -2.07
Current: -3.34

During the past 6 years, the highest EV-to-EBIT of MicroPort CardioFlow Medtech was -2.07. The lowest was -154.66. And the median was -16.64.

HKSE:02160's EV-to-EBIT is ranked worse than
100% of 457 companies
in the Medical Devices & Instruments industry
Industry Median: 20.37 vs HKSE:02160: -3.34

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MicroPort CardioFlow Medtech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$2,820.3 Mil. MicroPort CardioFlow Medtech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-502.8 Mil. MicroPort CardioFlow Medtech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -17.83%.


MicroPort CardioFlow Medtech EV-to-EBIT Historical Data

The historical data trend for MicroPort CardioFlow Medtech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech EV-to-EBIT Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - -33.81 -8.65 -5.61

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.81 - -8.65 - -5.61

Competitive Comparison of MicroPort CardioFlow Medtech's EV-to-EBIT

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort CardioFlow Medtech's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's EV-to-EBIT falls into.



MicroPort CardioFlow Medtech EV-to-EBIT Calculation

MicroPort CardioFlow Medtech's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1677.910/-502.774
=-3.34

MicroPort CardioFlow Medtech's current Enterprise Value is HK$1,677.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort CardioFlow Medtech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-502.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort CardioFlow Medtech  (HKSE:02160) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MicroPort CardioFlow Medtech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-502.774/2820.3406
=-17.83 %

MicroPort CardioFlow Medtech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$2,820.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort CardioFlow Medtech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-502.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort CardioFlow Medtech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Traded in Other Exchanges
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines